A study shows continued increase in antibiotic resistance is not inevitable and offers new insights to help monitor drug ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Thomas A. Russo, MD, SUNY Distinguished Professor and chief of infectious diseases at the Jacobs School, is co-author on a Nature Communications paper analyzing hypervirulent pneumoniae infections.

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...

The FDA has approved GSK’s gepotidacin, the first antibiotic for uncomplicated urinary tract infections in 30 years. The drug has been approved for female adults and adolescents with UTIs caused by ...

Mexican company Henkel Capital S.A. de C.V. recalled its contaminated Tec Italy shampoo that was distributed in New York and ...

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Empa researchers are therefore working on sensors that quickly identify resistant germs and recommend efficient treatment. The spread of antibiotic-resistant superbugs is plunging health care ...

Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...

Antibiotic resistance tends to stabilize over time, according to a study published in the open-access journal PLOS Pathogens ...